2 unknown, 1 not yet recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Unknown 1 |
Follow conteltinib: new trials by email Literature Review of conteltinib trials Research Report on conteltinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation SY-5933, CT-707 - Advanced Solid Tumor | Phase 1 / Phase 2 | Not yet recruiting | Shouyao Holdings (Beijing) Co. LTD | 102 | 2025-06-01 | 2025-05-14 |
| Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer CT-707, Toripalimab, Gemcitabine - Advanced Pancreatic Cancer | Phase 1 / Phase 2 | Unknown | Shouyao Holdings (Beijing) Co. LTD | 114 | 2022-08-11 | 2023-11-22 |
| Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer CT-707 - Non-small Cell Lung Cancer | Phase 1 | Unknown | Centaurus Biopharma Co., Ltd. | 40 | 2016-03-01 | 2017-03-09 |
Carcinoma, Non-Small-Cell Lung (1)
Shouyao Holdings (Beijing) Co. LTD (2) · Centaurus Biopharma Co., Ltd. (1)
China (3)
Yinghui Sun, PhD (2) · Yuankai Shi, Dr (1)